Tag: DSM Group

DSM Group is a Russia-wide сompany that regularly monitors all pharmaceutical sectors, including import, distribution, pharmaceuticals retail sales, hospital procurement and state procurement under the State Reimbursement Program. Moreover, the сompany monitors sales of non-medicinal products, including skin care products and parapharmaceuticals (biologically active additives, diagnostic devices, personal care products, and health care products, etc.)

Russian drugs displace imports from the market

drugs
The first shifts in import substitution and expansion of innovative pharmaceutical production facilities occurred under Pharma - 2020, a state program which started as early as in 2011.

Bayer, Novartis and Teva topped February sales rankings in Russia

pharmacy
According to DSM Group, in February 2018, the commercial market of medicinal products amounted to 80.6 billion rubles (in retail prices). Compared to January 2018, the market volume increased by 4.0%.

Russian pharmacy market increased by 6.5% in ruble terms in 2017

pills
In 2017, 5065.8 million packages of drugs worth 940.7 billion rubles (in retail prices) were sold through the pharmacies in Russia. This is 6.5% higher than in 2016 in value terms and 3.5% higher in physical terms.

Russian pharmaceutical market grew 7.5% in December 2017

drugs
In December 2017, the Russian commercial market of medicinal products was worth 69.3 billion rubles. Compared to November 2017, the market volume grew by 7.5%. On a year-over-year basis, the sales increased by 2.4%.

Russian pharmaceutical market expands by 13.3% in September 2017

drugs
According to DSM Group, in September 2017, the volume of commercial market for medicinal products was 59.6 billion rubles

Percentage of Russian-made drugs in healthcare procurement reached 72.4% in Q1

drugs
According to the hospital audit of Russian pharmaceutical market conducted by DSM Group, 203.9 million packages of medicinal products worth 45.9 billion rubles were purchased for healthcare facilities in Q1 2017

58% of medicines sold in Russia in April were produced domestically

drugs
According to the analytical report of DSM Group, in April 2017, the commercial market of medicinal products amounted to 53.9 billion rubles

Russian pharmaceutical market grew by 7% in 2016

drugs
According to the analytical report of DSM Group for 2016, the volume of the Russian pharmaceutical market reached 1344 billion rubles in 2016

The share of analgesics in packages on the Russian market is about 9%

According to the Russian pharmaceutical market audit by DSM Group, the analgesics occupy about 3% of the drug market in value terms, but the share in packages is much higher: about 9%. The main cha...